Search
Search Results
##search.searchResults.foundPlural##
-
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2212PDF: 1739HTML: 386 -
HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?
2947PDF: 1388HTML: 3583Untitled: 202Untitled: 215Untitled: 190 -
PROLIFERATION AND APOPTOSIS OF B-CELL LYMPHOMA CELLS UNDER TARGETED REGULATION OF FOXO3 BY miR-155 miR-155, FOXO3, B-cell lymphoma, proliferation, apoptosis, clinical characteristics
828PDF: 106HTML: 149 -
THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA
523PDF: 260HTML: 83 -
RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA MOLECULAR ALTERATIONS OCCURRING IN MM
1286PDF: 1087HTML: 219 -
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
1085PDF: 1195Suppl. Files: 574HTML: 94 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1425HTML: 484PDF: 845 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3856PDF: 1698HTML: 11658Figures Haase: 218 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
2029PDF: 744HTML: 690Table1: patient's characteristics: 162Table 2: profile of each patient: 186 -
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3400PDF: 1996HTML: 7484 -
PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma
2510HTML: 287PDF: 916 -
EPIDEMIOLOGICAL OVERVIEW OF HODGKIN LYMPHOMA ACROSS THE MEDITERRANEAN BASIN
3600PDF: 1249HTML: 5008Incidence age-standardized rates for HL across the Mediterranean basin: 219 -
NON-SECRETORY MYELOMA: READY FOR A NEW DEFINITION?
3309PDF: 1731HTML: 1103 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2625PDF: 818HTML: 5241 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
9207PDF: 6135HTML: 87985Fig.1b: 196Fig.1c: 204Fig.2a: 190Fig.2b: 190Fig.4: 206Fig.2c: 194Fig.3: 194Tab.1: 246Tab.2: 220Tab.3: 204Tab.4: 240Fig1a: 199 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1610PDF: 1059HTML: 263 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3627PDF: 2549HTML: 1525 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3713PDF: 912HTML: 6728 -
HEPARIN-BINDING PROTEIN AS A DIAGNOSTIC AND PROGNOSTIC MARKER OF INFECTIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS Heparin-binding protein in adult patients
2610PDF: 1029HTML: 179Suppl. Files: 525 -
SOLITARY PLASMACYTOMA
3982PDF: 2227HTML: 1252fIGURES 1,2: 234 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3112PDF: 890HTML: 7179Kost Fig1: 199Kost Fig 2: 191Kost Fig3: 193Kost Fig 4: 202Kost Fig5: 202Kost fig 6: 187 -
-
TYROSINE KINASE INHIBITORS AND PREGNANCY
3683PDF: 1692HTML: 2685 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2221PDF: 1631HTML: 321 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2517PDF: 801HTML: 1742 -
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
4062PDF: 1561HTML: 9194Untitled: 286Untitled: 193Untitled: 177Untitled: 171Untitled: 195Untitled: 350 -
MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN THE ELDERLY
2824PDF: 1145HTML: 3299 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
4033PDF: 1070HTML: 3607Untitled: 180Cneo. Fig.1: 117Untitled: 109Untitled: 136Untitled: 137 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2863PDF: 1034HTML: 5531 -
-
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4217PDF: 1965HTML: 5346Table 1: 219







